Measurement of Foxp3+CD4+ cells has the potential to aid in evaluating the presence of active inflammation, which cannot be evaluated by known Th1- and Th2-related markers in patients with allergic diseases [25]. This evidence concerns the gene FOXP3 and allergic disease.